Riddhi Siddhi Gluco Biols Limited (524480) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Riddhi Siddhi Gluco Biols Limited stock ₹412, price ₹656, that is 37.3% below the price, quality 48 out of 100. Rating: strongly overvalued. Calculated from audited financials with 2 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 7, 2026.
How to read this chart
60‑month range ₹310.24 – ₹825.90 · fair‑value band ₹276.16 – ₹640.22 · the ₹656.20 price screens above the ₹411.76 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 7, 2026.
Follow Riddhi Siddhi Gluco Biols in your weekly email
Every Wednesday you see whether Riddhi Siddhi Gluco Biols is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Riddhi Siddhi Gluco Biols Limited, together with its subsidiaries, engages in the trading of agriculture and metal commodities primarily in India. It operates through Trading Business, Wind Energy Generation, Paper Reprocessing, and Real Estate Business segments.
Show moreShow less
The company also generates and sells wind power; and manufactures and sells newsprint, writing, and printing papers. As of March 31, 2020, it operated windmills with a total capacity of 33.15 MW in Tamilnadu, Maharashtra, and Gujarat. The company was founded in 1990 and is based in Ahmedabad, India.
Stock analysis
Riddhi Siddhi Gluco Biols Limited (524480) currently trades at ₹656.20, while our model-based Fair Value estimate is ₹411.76, 37% below the price, so the stock looks overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 2 models at a data quality of 94/100, which puts the data coverage at low.
Scenario range: ₹276.16 (bear) to ₹640.22 (bull), the price of ₹656.20 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 48/100 (below-average quality), in the Consumer Goods sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Riddhi Siddhi Gluco Biols Limited reported revenue of ₹2.4B in FY2026 versus ₹2.2B in FY2022, a compound +1.4%/yr. Reported net income was −₹44.8M in FY2026.
Key figures
Market cap ₹1.7B (≈ $17.7M) Micro · P/E ratio 20.2 · P/S ratio 0.30 · EPS (TTM) ₹11.95 · Dividend yield 0.3% · Net margin 1.5% · Return on equity −0.3% · Return on assets (EBIT) −0.3% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 19 out of 100 (low confidence).
What moves the price
The share trades about 21% below its 52-week high and 60% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Consumer Goods peers we cover trades at 10% fair-value upside, at −37%, 524480 screens richer than that median.
Fair Value models
Bear₹276.16Fair Value ₹411.76Bull₹640.22
Price ₹656.20 · Downside -37.3%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 7 months old). Earnings retained since then (₹6.08 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
Owner Earnings₹138.08₹205.88₹320.1176
NCAV (Graham)₹288.48₹437.09₹546.3654
All 2 models by family
DCF Models
Owner Earnings₹138.08₹205.88₹320.1176
Asset-Based
NCAV (Graham)₹288.48₹437.09₹546.3654
The fair value above starts from this blend and is adjusted for a cyclical trough year.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.12/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+74.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−13.9%
Start year 2021 (pandemic). Over 10 years: −3.7% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−5.8%
’14
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−10.3% (2021) → −8.7% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2026 is a loss year, no rate is defined from a loss
Compare Riddhi Siddhi Gluco Biols Limited with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Farm Products · 291 stocks
Beats the industry median on 5/12 measures
A mixed picture versus its industry peers.
Valuation
Quality Score48 · Below median
Fair Value upside−37.3% · Below median
Profitability
Return on assets−0.2% · Below median
Net margin (12 months)1.5% · Below median
Operating margin (12 months)−2.5% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY)40.7% · Top 25%
Dividend yield (12 months)0.3% · Bottom 25%
Balance sheet
Debt / equity0.11× · Below median
Valuation Multiplesvs Farm Products median · lower = cheaper
P/E (12 months)20.2× · Pricier than median
P/B0.11× · Cheapest 25%
P/S (12 months)0.30× · Cheapest 25%
EV/EBITDA7.4× · Cheaper than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 27
FUTURE (revenue growth)100· sector 15
PAST (return on equity)0· sector 17
HEALTH (low debt)94· sector 94
DIVIDEND (yield)6· sector 41
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Riddhi Siddhi Gluco Biols Limited (524480) overvalued or undervalued?
As of Nov 7, 2026, our model estimates a fair value of ₹411.76 versus a price of ₹656.20, about 37% lower (overvalued).
What is the fair value of 524480?
Our model-based fair value for Riddhi Siddhi Gluco Biols Limited is ₹411.76 (as of Nov 7, 2026), built from audited fundamentals. The current price: ₹656.20.
What is the quality score of 524480?
Riddhi Siddhi Gluco Biols Limited has a Quality Score of 48/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Riddhi Siddhi Gluco Biols Limited (524480)?
Our model-based price target is the fair value of ₹411.76 (as of Nov 7, 2026) from 2 valuation models. Cautious scenario ₹276.16, optimistic scenario ₹640.22. It is a calculation from audited fundamentals, not an analyst target.
What is the Riddhi Siddhi Gluco Biols Limited stock forecast for 2026?
Our models put fair value at ₹411.76, about 37% lower versus a price of ₹656.20 (overvalued). Cautious scenario ₹276.16, optimistic scenario ₹640.22. The calculation is refreshed regularly with new filings.
What is the revenue of Riddhi Siddhi Gluco Biols Limited (524480)?
Riddhi Siddhi Gluco Biols Limited reported trailing-twelve-month revenue of about ₹5.5B (latest available figure, as of Nov 7, 2026).
Does Riddhi Siddhi Gluco Biols Limited pay a dividend?
Riddhi Siddhi Gluco Biols Limited currently shows a dividend yield of 0.30% relative to its recent price (as of Nov 7, 2026).
How much is the dividend of Riddhi Siddhi Gluco Biols Limited (524480)?
Riddhi Siddhi Gluco Biols Limited pays a dividend of ₹2.00 per share a year, a dividend yield of 0.3%. A dividend has been paid every year since 2022. The payout ratio is 16.7% of earnings. Our assessment: Token dividend. At a yield of 0.3% the dividend is symbolic. On paper it is not fully covered by earnings or free cash flow, but at this size that hardly matters: even scrapping it entirely would cost less than 0.3% a year, and coverage ratios on amounts this small swing with ordinary working-capital movements. Judge this company on its business, not on its dividend.
What is the intrinsic value of Riddhi Siddhi Gluco Biols Limited (524480)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Riddhi Siddhi Gluco Biols Limited it is ₹411.76 per share (as of Nov 7, 2026), against a price of ₹656.20. It is the blended result of 2 valuation models in 2 families (DCF Models, Asset-Based).
Is Riddhi Siddhi Gluco Biols Limited stock overvalued or undervalued in 2026?
As of Nov 7, 2026, 524480 trades above its calculated fair value: price ₹656.20, fair value ₹411.76, a gap of about −37% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 524480?
No. The price is what the market pays today (₹656.20); the fair value is what the company's own numbers justify (₹411.76). For Riddhi Siddhi Gluco Biols Limited the two are ₹244.44 per share apart. That gap is exactly why we show both numbers side by side.
How much is Riddhi Siddhi Gluco Biols Limited worth?
The market values Riddhi Siddhi Gluco Biols Limited at about ₹1.7B (market capitalisation, as of Nov 7, 2026). Per share that is ₹656.20; our models calculate a fair value of ₹411.76 per share.
What do the bullish and bearish scenarios say about 524480?
Our models span a range for Riddhi Siddhi Gluco Biols Limited: cautious scenario ₹276.16, base ₹411.76, optimistic ₹640.22 per share (as of Nov 7, 2026, price ₹656.20). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 524480?
Riddhi Siddhi Gluco Biols Limited trades at a price-to-earnings ratio of 20.2 (as of Nov 7, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹411.76 is built from several models across several years. Median P/E at fiscal year-end, 6 fiscal years (2018 to 2025), reported earnings: 12.4. Other multiples: P/B 0.1, P/S 0.3, EV/EBITDA 7.4.
How solid is the balance sheet of Riddhi Siddhi Gluco Biols Limited (524480)?
Balance-sheet figures for Riddhi Siddhi Gluco Biols Limited (as of Nov 7, 2026): return on equity −0.3%, debt of 0.11 per unit of equity. They feed the Quality Score of 48/100, which measures business quality independently of the share price.
How far is 524480 from its 52-week high?
Riddhi Siddhi Gluco Biols Limited trades at ₹656.20, about 21% below its 52-week high of ₹825.90 and 60% above the low of ₹411.20 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of ₹411.76 is for.
Which stocks are comparable to Riddhi Siddhi Gluco Biols Limited?
From the same area (Consumer Goods) we also value Muyuan Foods Group, Archer-Daniels-Midland Company, Tyson Foods, Inc, Bunge Global SA, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Riddhi Siddhi Gluco Biols Limited stock attractive at the current price?
The data as of Nov 7, 2026: price ₹656.20, calculated fair value ₹411.76 (−37%), Quality Score 48/100, from 2 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 524480 calculated?
We run Riddhi Siddhi Gluco Biols Limited through 2 models from 2 families: DCF Models, Asset-Based. Every model gets the same audited fundamentals; the fair value of ₹411.76 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Riddhi Siddhi Gluco Biols Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Riddhi Siddhi Gluco Biols Limited (524480)?
The closing price on Nov 6, 2026 was ₹656.20. Our model-based fair value is ₹411.76, about 37% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Riddhi Siddhi Gluco Biols Limited right now?
The price sits above even our optimistic bull case (₹640.22). The favourable scenario is already priced in. Weak quality (48/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (₹276.16 to ₹640.22) leaves room in how you read the outcome.
Key figures of Riddhi Siddhi Gluco Biols Limited
How large is the market capitalisation of Riddhi Siddhi Gluco Biols Limited (524480)?
The market capitalisation of Riddhi Siddhi Gluco Biols Limited is ₹1.7B (≈ $17.7M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Riddhi Siddhi Gluco Biols Limited (524480)?
The price-to-sales ratio of Riddhi Siddhi Gluco Biols Limited is 0.30 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Riddhi Siddhi Gluco Biols Limited (524480)?
Earnings per share at Riddhi Siddhi Gluco Biols Limited are ₹11.95 (price ÷ EPS = P/E 20.2). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Riddhi Siddhi Gluco Biols Limited (524480)?
The dividend yield of Riddhi Siddhi Gluco Biols Limited is 0.3% (payout 16.7%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Riddhi Siddhi Gluco Biols Limited (524480)?
The net margin of Riddhi Siddhi Gluco Biols Limited is 1.5% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Riddhi Siddhi Gluco Biols Limited (524480)?
The return on equity (ROE) of Riddhi Siddhi Gluco Biols Limited is −0.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Riddhi Siddhi Gluco Biols Limited (524480)?
On an EBIT basis the return on assets of Riddhi Siddhi Gluco Biols Limited is −0.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Riddhi Siddhi Gluco Biols Limited (524480)?
The operating margin of Riddhi Siddhi Gluco Biols Limited is −2.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Riddhi Siddhi Gluco Biols Limited (524480)?
Revenue at Riddhi Siddhi Gluco Biols Limited is growing +40.7% versus a year earlier (3y avg +10.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Riddhi Siddhi Gluco Biols Limited (524480) generate?
The free cash flow of Riddhi Siddhi Gluco Biols Limited is −₹95.6M (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Riddhi Siddhi Gluco Biols Limited (524480) carry?
The net debt of Riddhi Siddhi Gluco Biols Limited is ₹1.7B (fiscal year 2026). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Riddhi Siddhi Gluco Biols Limited in the live analysis
One click puts Riddhi Siddhi Gluco Biols Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Thin data
Nov 7, 2026